EPISODE · Mar 21, 2023 · 12 MIN
Operational Pathways for Biomarker Testing in NSCLC
from OnCall
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test results, clinical application of ctDNA testing as well as strategies for documentation of results for ease of retrieval. Sponsored by AmgenIf you have any questions for today’s guests, or have a topic you would like to hear more about, email [email protected].
Embed this episode
NOW PLAYING
Operational Pathways for Biomarker Testing in NSCLC
No transcript for this episode yet
Similar Episodes
No similar episodes found.